SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Concerns over Alphabets AI competitiveness, heavy infrastructure spending, and pressure on its search business are driving the discussion, amplified by speculation about an AI-development slowdown and rising rates. Traders remain divided, with bears citing valuation and capex risks while bulls point to Google Cloud, Gemini, TPUs, and Alphabets broader AI ecosystem.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Attention is centered on Duos pivot toward modular AI data-center infrastructure, highlighted by five-year 55 MW hosting agreements with Axe Compute and expectations for additional deployments. Traders are also reacting to a quarterly results beat and reaffirmed growth outlook, while debating execution speed, financing needs and potential dilution.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Anticipation of a NASA CLPS 2.0 contract award, reportedly pushed to September 22, is the main focus, with traders speculating about a sizable potential catalyst. Bulls also point to the successful SXM-11 handover to SiriusXM and expanding defense exposure, while bears cite dilution, weak price action and broader pressure on space stocks.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Pharvaris strong CHAPTER-3 data for oral deucrictibant has intensified concerns that the competitor could pressure BioCrysts Orladeyo market share and future revenue, driving sharp selling and unusually heavy volume. Traders are divided between viewing the reaction as justified competitive risk and calling it an overreaction, citing Orladeyos established commercial base and the time before Pharvaris can reach market.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

A funded Department of War CLEAR prototype agreement to advance LightPaths BlackDiamond germanium alternatives for military infrared systems is driving attention, with traders viewing it as validation and a potential path to follow-on production. The community is broadly bullish, though some debate whether broader NGSRI competition could delay or dilute the opportunity.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Regulatory uncertainty following the Senates failure to advance the CLARITY Act is driving attention and volatility in Circle, with traders debating whether the setback is already priced in. Bulls point to Arcs launch, stablecoin adoption and reserve-income benefits from higher rates, while bears argue the lost regulatory catalyst and growing competition weaken the thesis.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Attention is centered on Polkadots reported tokenomics overhaul, including a 2.1 billion DOT supply cap, reduced issuance, and potential burns tied to network revenue, alongside Polkadot 2.0/JAM developments. Traders are split between viewing tighter supply and recent high-volume rebounds as bullish catalysts and arguing that weak user demand and adoption could keep the long-term downtrend intact.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

New 52-week COMP360 data showing durable benefit in treatment-resistant depression, along with preparations for a rolling NDA submission and upcoming FDA scrutiny, is driving attention. Traders are broadly bullish on Compasss first-mover position, while debate continues over clinic economics, reimbursement, commercialization risk, and speculative buyout interest.

PolySwarm

Renewed trading volume and speculative momentum are drawing attention to PolySwarm, with traders positioning for a broader altcoin rebound and highlighting its cybersecurity utility and limited supply. Others remain cautious, describing the moves as recurring pump-and-dump activity and warning that NCT remains highly dependent on Bitcoin and overall crypto liquidity.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to investor anticipation surrounding upcoming clinical data presentations and interest in the company's lead drug candidate, soquelitinib. While some traders express optimism regarding institutional ownership and the drug's therapeutic potential, others remain skeptical, citing concerns about trial timelines, management performance, and recent share price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
